Eltrombopag Olamine Tablet, Film Coated
Product Images NDC 42291-933

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eltrombopag Olamine (NDC 42291-933). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (932 30)

FDA Label Image

1 (933 30)

1 (933 30)
This is a description of Eltrombopag tablets, containing 25 mg of Eltrombopag olamine per film-coated tablet. The recommended dosage information is available in the prescribing information. The tablets should be stored at room temperature and dispensed in the original bottle with safety closures intact. The manufacturer is AVKARE and the tablets have 30 tablets per bottle. The text also provides the address of the manufacturer in Pulaski, TN.*
FDA Label Image

1 (934 30)

1 (934 30)
This text provides details about a pharmaceutical product containing eftrombopag olamine, with dosage recommendations and storage instructions. The tablets should be stored at room temperature between 20° to 25°C (68° to 77°F). Dispensing should be done in the original bottle, and safety precautions must be followed. It is important not to chew, crush, or split the tablets. The text also includes contact information for the manufacturer and a space for recording lot number and expiration date.*
FDA Label Image

1 (935 30)

1 (935 30)
This text provides information about a medication containing eltrombopag olamine, with each film-coated tablet containing 95.70 mg equivalent to 75 mg of eltrombopag free acid. The recommended dosage and storage instructions are also given, advising to store the tablets at room temperature and not to chew or crush them. Additionally, it mentions safety precautions and the manufacturer details.*
FDA Label Image

Structural Formula (Eltrombopag Tablets Us 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.